메뉴 건너뛰기




Volumn 28, Issue 4 C, 2008, Pages 2459-2467

Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases

Author keywords

5 Fluorouracil; Arterial; Cetuximab; Colorectal; Infusion; Irinotecan; Metastases; Oxaliplatin

Indexed keywords

ANTIBIOTIC AGENT; BUPRENORPHINE; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; ELVORIN; FLUCLOXACILLIN; FLUOROURACIL; FOLIC ACID; IRINOTECAN; MINOCYCLINE; OCTREOTIDE; OXALIPLATIN; PROTON PUMP INHIBITOR; TRAMADOL;

EID: 48849087988     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (14)

References (42)
  • 1
    • 27144540666 scopus 로고    scopus 로고
    • Mortality and survival in breast and colorectal cancer
    • Boyle P and Ferlay J: Mortality and survival in breast and colorectal cancer. Nat Clin Pract Oncol 2: 424-425, 2005.
    • (2005) Nat Clin Pract Oncol , vol.2 , pp. 424-425
    • Boyle, P.1    Ferlay, J.2
  • 2
    • 4644320061 scopus 로고    scopus 로고
    • Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F and Bismuth H: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657; discussion 657-648, 2004.
    • Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F and Bismuth H: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657; discussion 657-648, 2004.
  • 5
    • 34249000361 scopus 로고    scopus 로고
    • Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crino L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M and Masi G: Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25: 1670-1676, 2007.
    • Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crino L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M and Masi G: Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25: 1670-1676, 2007.
  • 6
    • 0037531121 scopus 로고    scopus 로고
    • Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial
    • Rothenberg MI, Oza Am, Bigelow Rh, Berlin Jd, Marshall JI, Ramanathan Rk, Hart LI, Gupta S, Garay Ca, Burger Bg, Le Bail N and Haller Dg: Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 21: 2059-2069, 2003.
    • (2003) J Clin Oncol , vol.21 , pp. 2059-2069
    • Rothenberg, M.I.1    Oza, A.2    Bigelow, R.3    Berlin, J.4    Marshall, J.I.5    Ramanathan, R.6    Hart, L.I.7    Gupta, S.8    Garay, C.9    Burger, B.10    Le Bail, N.11    Haller, D.12
  • 9
    • 34248173883 scopus 로고    scopus 로고
    • Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA and Benson AB, 3rd: Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25: 1539-1544, 2007.
    • Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA and Benson AB, 3rd: Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25: 1539-1544, 2007.
  • 10
    • 23844448040 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates
    • Folprecht G, Grothey A, Alberts S, Raab H and Kohne C: Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16: 1311-1319, 2005.
    • (2005) Ann Oncol , vol.16 , pp. 1311-1319
    • Folprecht, G.1    Grothey, A.2    Alberts, S.3    Raab, H.4    Kohne, C.5
  • 11
    • 33746485766 scopus 로고    scopus 로고
    • Epidermal growth factor receptor targeting in cancer
    • Mendelsohn J and Baselga J: Epidermal growth factor receptor targeting in cancer. Semin Oncol 33: 369-385, 2006.
    • (2006) Semin Oncol , vol.33 , pp. 369-385
    • Mendelsohn, J.1    Baselga, J.2
  • 13
    • 0842278693 scopus 로고    scopus 로고
    • Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: Oxaliplatin pharmacokinetics and feasibility
    • Guthoff I, Lotspeich E, Fester C, Wallin I, Schatz M, Ehrsson H and Kornmann M: Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Anticancer Res 23: 5203-5208, 2003.
    • (2003) Anticancer Res , vol.23 , pp. 5203-5208
    • Guthoff, I.1    Lotspeich, E.2    Fester, C.3    Wallin, I.4    Schatz, M.5    Ehrsson, H.6    Kornmann, M.7
  • 15
    • 34447264101 scopus 로고    scopus 로고
    • Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial
    • Van Cutsem E, Nowacki M, Lang I, Cascinu S, Shchepotin I, Maurel J, Rougier P, Cunningham D, Nippgen J and Kohne C: Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial. ASCO Meeting Abstracts 25: 4000, 2007.
    • (2007) ASCO Meeting Abstracts , vol.25 , pp. 4000
    • Van Cutsem, E.1    Nowacki, M.2    Lang, I.3    Cascinu, S.4    Shchepotin, I.5    Maurel, J.6    Rougier, P.7    Cunningham, D.8    Nippgen, J.9    Kohne, C.10
  • 17
    • 34147103678 scopus 로고    scopus 로고
    • Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
    • Van Cutsem E, Peeters M, Siena S, Humblet Y, Hendlisz A, Neyns B, Canon J, Van Laethem J, Maurel J, Richardson G, Wolf M and Amado R: Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 25: 1658-1664, 2007.
    • (2007) J Clin Oncol , vol.25 , pp. 1658-1664
    • Van Cutsem, E.1    Peeters, M.2    Siena, S.3    Humblet, Y.4    Hendlisz, A.5    Neyns, B.6    Canon, J.7    Van Laethem, J.8    Maurel, J.9    Richardson, G.10    Wolf, M.11    Amado, R.12
  • 19
    • 0345447199 scopus 로고    scopus 로고
    • An update on hepatic arterial infusion chemotherapy for colorectal cancer
    • Cohen A and Kemeny N: An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 8: 553-566, 2003.
    • (2003) Oncologist , vol.8 , pp. 553-566
    • Cohen, A.1    Kemeny, N.2
  • 20
    • 33947267189 scopus 로고    scopus 로고
    • Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
    • Zorzi D, Laurent A, Pawlik T, Lauwers G, Vauthey J and Abdalla E: Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94: 274-286, 2007.
    • (2007) Br J Surg , vol.94 , pp. 274-286
    • Zorzi, D.1    Laurent, A.2    Pawlik, T.3    Lauwers, G.4    Vauthey, J.5    Abdalla, E.6
  • 21
    • 37649015497 scopus 로고    scopus 로고
    • Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: The end of an era?
    • Mocellin S, Pilati P, Lise M and Nitti D: Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 25: 5649-5654, 2007.
    • (2007) J Clin Oncol , vol.25 , pp. 5649-5654
    • Mocellin, S.1    Pilati, P.2    Lise, M.3    Nitti, D.4
  • 23
    • 0037308489 scopus 로고    scopus 로고
    • Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial
    • Kerr D, Mcardle C, Ledermann J, Taylor I, Sherlock D, Schlag PM, Buckels J, Mayer D, Cain D and Stephens R: Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361: 368-373, 2003.
    • (2003) Lancet , vol.361 , pp. 368-373
    • Kerr, D.1    Mcardle, C.2    Ledermann, J.3    Taylor, I.4    Sherlock, D.5    Schlag, P.M.6    Buckels, J.7    Mayer, D.8    Cain, D.9    Stephens, R.10
  • 24
    • 0343048340 scopus 로고    scopus 로고
    • Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma
    • Lorenz M and Muller H: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18: 243-254, 2000.
    • (2000) J Clin Oncol , vol.18 , pp. 243-254
    • Lorenz, M.1    Muller, H.2
  • 25
    • 34547663856 scopus 로고    scopus 로고
    • The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and ultra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: A phase II study
    • Carnaghi C, Santoro A, Rimassa L, Doci R, Rosati R, Pedicini V, Gullo G, Zuradelli M, Abbadessa G, Morenghi E, Marcon I and Garassino I: The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and ultra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study. Invest New Drugs 25: 479-485, 2007.
    • (2007) Invest New Drugs , vol.25 , pp. 479-485
    • Carnaghi, C.1    Santoro, A.2    Rimassa, L.3    Doci, R.4    Rosati, R.5    Pedicini, V.6    Gullo, G.7    Zuradelli, M.8    Abbadessa, G.9    Morenghi, E.10    Marcon, I.11    Garassino, I.12
  • 26
    • 0034994629 scopus 로고    scopus 로고
    • Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer
    • Kern W, Beckert B, Lang N, Stemmler J, Beykirch M, Stein J, Goecke E, Waggershauser T, Braess J, Schalhorn A and Hiddemann W: Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 12: 599-603, 2001.
    • (2001) Ann Oncol , vol.12 , pp. 599-603
    • Kern, W.1    Beckert, B.2    Lang, N.3    Stemmler, J.4    Beykirch, M.5    Stein, J.6    Goecke, E.7    Waggershauser, T.8    Braess, J.9    Schalhorn, A.10    Hiddemann, W.11
  • 27
    • 0034451952 scopus 로고    scopus 로고
    • Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: Role of carcino-embryonic antigen in assessment of response
    • Kern W, Beckert B, Lang N, Waggershauser T, Braess J, Schalhorn A and Hiddemann W: Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response. Anticancer Res 20: 4973-4975, 2000.
    • (2000) Anticancer Res , vol.20 , pp. 4973-4975
    • Kern, W.1    Beckert, B.2    Lang, N.3    Waggershauser, T.4    Braess, J.5    Schalhorn, A.6    Hiddemann, W.7
  • 30
    • 24644443860 scopus 로고    scopus 로고
    • Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
    • Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob J, Boige V, Elias D, Delperro J and Luboinski M: Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 23: 4881-4887, 2005.
    • (2005) J Clin Oncol , vol.23 , pp. 4881-4887
    • Ducreux, M.1    Ychou, M.2    Laplanche, A.3    Gamelin, E.4    Lasser, P.5    Husseini, F.6    Quenet, F.7    Viret, F.8    Jacob, J.9    Boige, V.10    Elias, D.11    Delperro, J.12    Luboinski, M.13
  • 31
    • 24644484863 scopus 로고    scopus 로고
    • Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
    • Kemeny N, Jarnagin W, Paty P, Gonen M, Schwarte L, Morse M, Leonard G, D'angelica M, Dematteo R, Blumgart L and Fong Y: Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23: 4888-4896, 2005.
    • (2005) J Clin Oncol , vol.23 , pp. 4888-4896
    • Kemeny, N.1    Jarnagin, W.2    Paty, P.3    Gonen, M.4    Schwarte, L.5    Morse, M.6    Leonard, G.7    D'angelica, M.8    Dematteo, R.9    Blumgart, L.10    Fong, Y.11
  • 32
    • 38049164083 scopus 로고    scopus 로고
    • Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
    • Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M and Ducreux M: Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 15: 219-226, 2008.
    • (2008) Ann Surg Oncol , vol.15 , pp. 219-226
    • Boige, V.1    Malka, D.2    Elias, D.3    Castaing, M.4    De Baere, T.5    Goere, D.6    Dromain, C.7    Pocard, M.8    Ducreux, M.9
  • 33
    • 37349026722 scopus 로고    scopus 로고
    • Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis
    • Gallagher D, Capanu M, Raggio G and Kemeny N: Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol 18: 1995-1999, 2007.
    • (2007) Ann Oncol , vol.18 , pp. 1995-1999
    • Gallagher, D.1    Capanu, M.2    Raggio, G.3    Kemeny, N.4
  • 34
    • 33947705790 scopus 로고    scopus 로고
    • Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases
    • Van Nieuwenhove Y, Aerts M, Neyns B and Delvaux G: Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases. Eur J Surg Oncol 33: 336-340, 2007.
    • (2007) Eur J Surg Oncol , vol.33 , pp. 336-340
    • Van Nieuwenhove, Y.1    Aerts, M.2    Neyns, B.3    Delvaux, G.4
  • 35
    • 34249670190 scopus 로고    scopus 로고
    • Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A Phase II-study and historical comparison with the surgical approach
    • Hildebrandt B, Pech M, Nicolaou A, Langrehr J, Kurcz J, Bartels B, Miersch A, Felix R, Neuhaus P, Riess H, Dorken B and Ricke J: Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach. BMC Cancer 7: 69, 2007.
    • (2007) BMC Cancer , vol.7 , pp. 69
    • Hildebrandt, B.1    Pech, M.2    Nicolaou, A.3    Langrehr, J.4    Kurcz, J.5    Bartels, B.6    Miersch, A.7    Felix, R.8    Neuhaus, P.9    Riess, H.10    Dorken, B.11    Ricke, J.12
  • 36
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • Therasse P, Arbuck Smeetingg, Eisenhauer E, Wanders J, Kaplan R, Rubinstein L, Verweij J, Van Glabbeke M, Van Oosterom A, Christian M and Gwyther S: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Smeetingg, A.2    Eisenhauer, E.3    Wanders, J.4    Kaplan, R.5    Rubinstein, L.6    Verweij, J.7    Van Glabbeke, M.8    Van Oosterom, A.9    Christian, M.10    Gwyther, S.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.